Naitee Ting – författare

Visar alla böcker från författaren Naitee Ting. Handla med fri frakt och snabb leverans.

19 produkter

Kategorier

19 produkter

Fundamental Concepts for New Clinical Trialists
AvScott Evans,Naitee Ting
Häftad, Engelska, 2021
817 kr
Skickas inom 10-15 vardagar
Fundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks. The first section of the book provides background information about clinical trials. It defines and compares clinical trials to other types of research studies and discusses clinical trial phases, registration, the protocol document, ethical issues, product development, and regulatory processes. It also includes a special chapter outlining the valuable attributes that statisticians can develop to maximize their contributions to a clinical trial. The second section examines scientific issues faced in each progressive step of a clinical trial. It covers issues in trial design, such as randomization, blinding, control-group selection, endpoint selection, superiority versus noninferiority, and parallel group versus crossover designs; data monitoring; analyses of efficacy, safety, and benefit-risk; and the reporting/publication of clinical trial results.As clinical trials remain the gold standard research studies for evaluating the effects of a medical intervention, newcomers to the field must have a fundamental understanding of the concepts to tackle real-world issues in all stages of trials. Drawing on their experiences in academia and industry, the authors provide a foundation for understanding the fundamental concepts necessary for working in clinical trials.
Dose Finding in Drug Development
AvNaitee Ting
Inbunden, Engelska, 2006
1 888 kr
Skickas inom 10-15 vardagar
This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose–responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose–response relationship is one of the most important act- ities in developing a new drug. A clinical development program for a new drug can be broadly divided into four phases – namely Phases I, II, III, and IV. Phase I clinical trials are designed to study the clinical pharmacology. Information - tained from these studies will help in designing Phase II studies. Dose–response relationshipsareusuallystudiedinPhaseII.PhaseIIIclinicaltrialsarelarge-scale, long-term studies. These studies serve to con?rm ?ndings from Phases I and II. ResultsobtainedfromPhasesI,II,andIIIclinicaltrialswouldthenbedocumented and submitted to regulatory agencies for drug approval. In the United States, - viewers from Food and Drug Administration (FDA) review these documents and make a decision to approve or to reject this New Drug Application (NDA). If the new drug is approved, then Phase IV studies can be started. Phase IV clinical trials are also known as postmarketing studies.
Dose Finding in Drug Development
AvNaitee Ting
E-bok
PDF, Engelska, 2006
1 798 kr
Läs direkt efter köp
This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose–responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose–response relationship is one of the most important act- ities in developing a new drug. A clinical development program for a new drug can be broadly divided into four phases – namely Phases I, II, III, and IV. Phase I clinical trials are designed to study the clinical pharmacology. Information - tained from these studies will help in designing Phase II studies. Dose–response relationshipsareusuallystudiedinPhaseII.PhaseIIIclinicaltrialsarelarge-scale, long-term studies. These studies serve to con?rm ?ndings from Phases I and II. ResultsobtainedfromPhasesI,II,andIIIclinicaltrialswouldthenbedocumented and submitted to regulatory agencies for drug approval. In the United States, - viewers from Food and Drug Administration (FDA) review these documents and make a decision to approve or to reject this New Drug Application (NDA). If the new drug is approved, then Phase IV studies can be started. Phase IV clinical trials are also known as postmarketing studies.
Fundamental Concepts for New Clinical Trialists
AvScott Evans,Naitee Ting
E-bok
Engelska, 2015
950 kr
Läs direkt efter köp
Fundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks. The first section of the book provides background information about clinical trials. I
Clinical Trials in the Era of Real-World Evidence
AvJie Chen,Naitee Tingm. fl.
Häftad, Engelska, 2026
1 315 kr
Skickas inom 5-8 vardagar
Integrate RCTs and real-world evidence for stronger regulatory submissionsSince the passage of the 21st Century Cures Act, the landscape of clinical research has transformed dramatically. Today, the integration of real-world data (RWD) and real-world evidence (RWE) with traditional randomized controlled trials (RCTs) is not just innovative - it is essential for modern drug development and regulatory decision-making.This comprehensive volume bridges the methodologies of conventional RCTs and emerging RWE studies, offering systematic approaches for leveraging diverse data sources throughout the clinical development lifecycle. Grounded in regulatory statistics yet forward-looking in scope, the book explores Stein's continuum of study designs - from traditional RCTs to pragmatic trials and observational studies - and demonstrates how RWD can enhance trial feasibility, inform outcome selection, provide external controls for single-arm trials, and strengthen post-approval safety monitoring.Readers will find detailed explorations of: A history of clinical trials, evidence-based medicine, and the regulatory frameworks governing drug approvalTreatment switching and estimands in RWE studiesAdvanced analytical considerations including precision medicine, vaccine effectiveness, safety evaluation, and sensitivity analysisPractical roadmaps for designing robust RWE studiesArtificial intelligence and machine learning in clinical researchDesigned as both a reference and a graduate-level textbook, this book serves clinical researchers such as clinicians and biostatisticians, regulatory professionals, public health scientists, and industry practitioners seeking to harness the power of RWD and RWE to generate credible, actionable evidence for modern medicine.
Clinical Trials in the Era of Real-World Evidence
AvFeinan Lu,Naitee Tingm. fl.
E-bok
PDF, Engelska, 2026
1 642 kr
Läs direkt efter köp
Integrate RCTs and real-world evidence for stronger regulatory submissions
Since the passage of the 21st Century Cures Act, the landscape of clinical research has transformed dramatically. Today, the integration of real-world data (RWD) and real-world evidence (RWE) with traditional randomized controlled trials (RCTs) is not just innovative - it is essential for modern drug development and regulatory decision-making.
This comprehensive volume bridges the methodologies of conventional RCTs and emerging RWE studies, offering systematic approaches for leveraging diverse data sources throughout the clinical development lifecycle. Grounded in regulatory statistics yet forward-looking in scope, the book explores Stein???s continuum of study designs - from traditional RCTs to pragmatic trials and observational studies - and demonstrates how RWD can enhance trial feasibility, inform outcome selection, provide external controls for single-arm trials, and strengthen post-approval safety monitoring.
Readers will find detailed explorations of:
A history of clinical trials, evidence-based medicine, and the regulatory frameworks governing drug approval Treatment switching and estimands in RWE studies Advanced analytical considerations including precision medicine, vaccine effectiveness, safety evaluation, and sensitivity analysis Practical roadmaps for designing robust RWE studies Artificial intelligence and machine learning in clinical research
Designed as both a reference and a graduate-level textbook, this book serves clinical researchers such as clinicians and biostatisticians, regulatory professionals, public health scientists, and industry practitioners seeking to harness the power of RWD and RWE to generate credible, actionable evidence for modern medicine.
Clinical Trials in the Era of Real-World Evidence
AvFeinan Lu,Naitee Tingm. fl.
E-bok
Engelska, 2026
1 630 kr
Läs direkt efter köp
Integrate RCTs and real-world evidence for stronger regulatory submissions Since the passage of the 21st Century Cures Act, the landscape of clinical research has transformed dramatically. Today, the integration of real-world data (RWD) and real-world evidence (RWE) with traditional randomized controlled trials (RCTs) is not just innovative - it is essential for modern drug development and regulatory decision-making. This comprehensive volume bridges the methodologies of conventional RCTs and emerging RWE studies, offering systematic approaches for leveraging diverse data sources throughout the clinical development lifecycle. Grounded in regulatory statistics yet forward-looking in scope, the book explores Stein's continuum of study designs - from traditional RCTs to pragmatic trials and observational studies - and demonstrates how RWD can enhance trial feasibility, inform outcome selection, provide external controls for single-arm trials, and strengthen post-approval safety monitoring. Readers will find detailed explorations of: A history of clinical trials, evidence-based medicine, and the regulatory frameworks governing drug approval Treatment switching and estimands in RWE studies Advanced analytical considerations including precision medicine, vaccine effectiveness, safety evaluation, and sensitivity analysis Practical roadmaps for designing robust RWE studies Artificial intelligence and machine learning in clinical research Designed as both a reference and a graduate-level textbook, this book serves clinical researchers such as clinicians and biostatisticians, regulatory professionals, public health scientists, and industry practitioners seeking to harness the power of RWD and RWE to generate credible, actionable evidence for modern medicine.
Fundamental Concepts for New Clinical Trialists
AvScott Evans,Naitee Ting
Inbunden, Engelska, 2015
1 538 kr
Skickas inom 10-15 vardagar
Fundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks. The first section of the book provides background information about clinical trials. It defines and compares clinical trials to other types of research studies and discusses clinical trial phases, registration, the protocol document, ethical issues, product development, and regulatory processes. It also includes a special chapter outlining the valuable attributes that statisticians can develop to maximize their contributions to a clinical trial. The second section examines scientific issues faced in each progressive step of a clinical trial. It covers issues in trial design, such as randomization, blinding, control-group selection, endpoint selection, superiority versus noninferiority, and parallel group versus crossover designs; data monitoring; analyses of efficacy, safety, and benefit-risk; and the reporting/publication of clinical trial results.As clinical trials remain the gold standard research studies for evaluating the effects of a medical intervention, newcomers to the field must have a fundamental understanding of the concepts to tackle real-world issues in all stages of trials. Drawing on their experiences in academia and industry, the authors provide a foundation for understanding the fundamental concepts necessary for working in clinical trials.
Dose Finding in Drug Development
AvNaitee Ting
Häftad, Engelska, 2010
1 711 kr
Skickas inom 10-15 vardagar
This book emphasizes dose selection issues from a statistical point of view. It presentsstatisticalapplicationsinthedesignandanalysisofdose–responsestudies. The importance of this subject can be found from the International Conference on Harmonization (ICH) E4 Guidance document. Establishing the dose–response relationship is one of the most important act- ities in developing a new drug. A clinical development program for a new drug can be broadly divided into four phases – namely Phases I, II, III, and IV. Phase I clinical trials are designed to study the clinical pharmacology. Information - tained from these studies will help in designing Phase II studies. Dose–response relationshipsareusuallystudiedinPhaseII.PhaseIIIclinicaltrialsarelarge-scale, long-term studies. These studies serve to con?rm ?ndings from Phases I and II. ResultsobtainedfromPhasesI,II,andIIIclinicaltrialswouldthenbedocumented and submitted to regulatory agencies for drug approval. In the United States, - viewers from Food and Drug Administration (FDA) review these documents and make a decision to approve or to reject this New Drug Application (NDA). If the new drug is approved, then Phase IV studies can be started. Phase IV clinical trials are also known as postmarketing studies.
Fundamental Concepts for New Clinical Trialists
AvScott Evans,Naitee Ting
E-bok
PDF, Engelska, 2015
950 kr
Läs direkt efter köp
Fundamental Concepts for New Clinical Trialists describes the core scientific concepts of designing, data monitoring, analyzing, and reporting clinical trials as well as the practical aspects of trials not typically discussed in statistical methodology textbooks. The first section of the book provides background information about clinical trials. I
Design and Analysis of Subgroups with Biopharmaceutical Applications
AvNaitee Ting,Joseph C. Cappellerim. fl.
Inbunden, Engelska, 2020
1 488 kr
Skickas inom 10-15 vardagar
This book provides an overview of the theories and applications on subgroups in the biopharmaceutical industry. Drawing from a range of expert perspectives in academia and industry, this collection offers an overarching dialogue about recent advances in biopharmaceutical applications, novel statistical and methodological developments, and potential future directions.The volume covers topics in subgroups in clinical trial design; subgroup identification and personalized medicine; and general issues in subgroup analyses, including regulatory ones. Included chapters present current methods, theories, and case applications in the diverse field of subgroup application and analysis. Offering timely perspectives from a range of authoritative sources, the volume is designed to have wide appeal to professionals in the pharmaceutical industry and to graduate students and researchers in academe and government.
Design and Analysis of Subgroups with Biopharmaceutical Applications
Av(Din) Ding-Geng Chen,Shuyen Hom. fl.
E-bok
Engelska, 2020
1 298 kr
Läs direkt efter köp
This book provides an overview of the theories and applications on subgroups in the biopharmaceutical industry. Drawing from a range of expert perspectives in academia and industry, this collection offers an overarching dialogue about recent advances in biopharmaceutical applications, novel statistical and methodological developments, and potential future directions.
The volume covers topics in subgroups in clinical trial design; subgroup identification and personalized medicine; and general issues in subgroup analyses, including regulatory ones. Included chapters present current methods, theories, and case applications in the diverse field of subgroup application and analysis. Offering timely perspectives from a range of authoritative sources, the volume is designed to have wide appeal to professionals in the pharmaceutical industry and to graduate students and researchers in academe and government.
Design and Analysis of Subgroups with Biopharmaceutical Applications
AvNaitee Ting,Joseph C. Cappellerim. fl.
Häftad, Engelska, 2021
1 033 kr
Skickas inom 10-15 vardagar
This book provides an overview of the theories and applications on subgroups in the biopharmaceutical industry. Drawing from a range of expert perspectives in academia and industry, this collection offers an overarching dialogue about recent advances in biopharmaceutical applications, novel statistical and methodological developments, and potential future directions.The volume covers topics in subgroups in clinical trial design; subgroup identification and personalized medicine; and general issues in subgroup analyses, including regulatory ones. Included chapters present current methods, theories, and case applications in the diverse field of subgroup application and analysis. Offering timely perspectives from a range of authoritative sources, the volume is designed to have wide appeal to professionals in the pharmaceutical industry and to graduate students and researchers in academe and government.
Applied Statistics in Biomedicine and Clinical Trials Design
Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings
AvZhen Chen,Aiyi Lium. fl.
Inbunden, Engelska, 2015
1 716 kr
Skickas inom 10-15 vardagar
This volume is a unique combination of papers that cover critical topics in biostatistics from academic, government, and industry perspectives. The 6 sections cover Bayesian methods in biomedical research; Diagnostic medicine and classification; Innovative Clinical Trials Design; Modelling and Data Analysis; Personalized Medicine; and Statistical Genomics. The real world applications are in clinical trials, diagnostic medicine and genetics. The peer-reviewed contributions were solicited and selected from some 400 presentations at the annual meeting of the International Chinese Statistical Association (ICSA), held with the International Society for Biopharmaceutical Statistics (ISBS). The conference was held in Bethesda in June 2013, and the material has been subsequently edited and expanded to cover the most recent developments.
Applied Statistics in Biomedicine and Clinical Trials Design
Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings
AvYi Tsong,Naitee Tingm. fl.
E-bok
PDF, Engelska, 2015
2 127 kr
Läs direkt efter köp
This volume is a unique combination of papers that cover critical topics in biostatistics from academic, government, and industry perspectives. The 6 sections cover Bayesian methods in biomedical research; Diagnostic medicine and classification; Innovative Clinical Trials Design; Modelling and Data Analysis; Personalized Medicine; and Statistical Genomics. The real world applications are in clinical trials, diagnostic medicine and genetics. The peer-reviewed contributions were solicited and selected from some 400 presentations at the annual meeting of the International Chinese Statistical Association (ICSA), held with the International Society for Biopharmaceutical Statistics (ISBS). The conference was held in Bethesda in June 2013, and the material has been subsequently edited and expanded to cover the most recent developments.
Applied Statistics in Biomedicine and Clinical Trials Design
Selected Papers from 2013 ICSA/ISBS Joint Statistical Meetings
AvZhen Chen,Aiyi Lium. fl.
Häftad, Engelska, 2016
1 716 kr
Skickas inom 10-15 vardagar
This volume is a unique combination of papers that cover critical topics in biostatistics from academic, government, and industry perspectives. The 6 sections cover Bayesian methods in biomedical research; Diagnostic medicine and classification; Innovative Clinical Trials Design; Modelling and Data Analysis; Personalized Medicine; and Statistical Genomics. The real world applications are in clinical trials, diagnostic medicine and genetics. The peer-reviewed contributions were solicited and selected from some 400 presentations at the annual meeting of the International Chinese Statistical Association (ICSA), held with the International Society for Biopharmaceutical Statistics (ISBS). The conference was held in Bethesda in June 2013, and the material has been subsequently edited and expanded to cover the most recent developments.
Phase II Clinical Development of New Drugs
AvNaitee Ting,Ding-Geng Chenm. fl.
Inbunden, Engelska, 2017
1 374 kr
Skickas inom 10-15 vardagar
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Phase II Clinical Development of New Drugs
AvJoseph C. Cappelleri,Shuyen Hom. fl.
E-bok
Engelska, 2017
1 798 kr
Läs direkt efter köp
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Phase II Clinical Development of New Drugs
AvNaitee Ting,Ding-Geng Chenm. fl.
Häftad, Engelska, 2018
1 374 kr
Skickas inom 10-15 vardagar
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.

Företag, bibliotek eller offentlig verksamhet?

Naitee Ting – författare

Fundamental Concepts for New Clinical Trialists

Dose Finding in Drug Development

Dose Finding in Drug Development

Fundamental Concepts for New Clinical Trialists

Clinical Trials in the Era of Real-World Evidence

Clinical Trials in the Era of Real-World Evidence

Clinical Trials in the Era of Real-World Evidence

Fundamental Concepts for New Clinical Trialists

Dose Finding in Drug Development

Fundamental Concepts for New Clinical Trialists

Design and Analysis of Subgroups with Biopharmaceutical Applications

Design and Analysis of Subgroups with Biopharmaceutical Applications

Design and Analysis of Subgroups with Biopharmaceutical Applications

Applied Statistics in Biomedicine and Clinical Trials Design

Applied Statistics in Biomedicine and Clinical Trials Design

Applied Statistics in Biomedicine and Clinical Trials Design

Phase II Clinical Development of New Drugs

Phase II Clinical Development of New Drugs

Phase II Clinical Development of New Drugs

Mina sidor

Mina sidor

Hjälp

Hjälp

Om Bokus

Om Bokus

Populärt

Populärt

Inspiration

Inspiration